Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
22.86
+0.11 (0.48%)
Aug 10, 2026, 3:04 PM CST
SHE:002773 Market Cap
SHE:002773 has a market cap or net worth of 20.96 billion as of August 7, 2026. Its market cap has decreased by -46.18% in one year.
Market Cap
20.96B
Enterprise Value
14.22B
Revenue
4.43B
Ranking
n/a
PE Ratio
19.62
Stock Price
22.86
ChartMarket Cap Chart
Since June 26, 2015, SHE:002773's market cap has increased from 8.74B to 20.96B, an increase of 139.87%. That is a compound annual growth rate of 8.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 20.96B | -24.09% |
| Dec 31, 2025 | 27.61B | 53.16% |
| Dec 31, 2024 | 18.03B | 6.33% |
| Dec 29, 2023 | 16.95B | 17.53% |
| Dec 30, 2022 | 14.43B | -22.90% |
| Dec 31, 2021 | 18.71B | -57.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Livzon Pharmaceutical Group | 24.87B |
| Guangdong Zhongsheng Pharmaceutical | 24.29B |
| Hubei Jumpcan Pharmaceutical | 23.87B |
| Tasly Pharmaceutical Group | 23.48B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.18B |
| Hybio Pharmaceutical | 21.53B |
| Jilin Aodong Pharmaceutical Group | 21.26B |
| Walvax Biotechnology | 21.02B |